Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective conventional TACE versus doxorubicin-loaded microsphere TACE in hepatocellular carcinoma
2006-003034-15Phase 4Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jul 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of doxorubicin in hepatocellular carcinoma (HCC) (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Started Jul 2007; status: completed.
02
Drugs
doxorubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2006-003034-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003034-15.